Pantethine

DB11190ApprovedSmall molecule

Pantethine is a naturally occurring compound derived from panthothenic acid. It acts as an intermediate in endogenous coenzyme A synthesis and is used as a dietary supplement to treat hypertriglyceridemia. It consists of two molecules of pantetheine that form a dimer via disufide linkages, and acts as an intermediate in the production of Coenzyme A.

Chemical structure of Pantethine
Mechanism
Curator reviewed
Formula / weight
C22H42N4O8S2 · 554.721 g/mol (avg)
Also known as
D-pantethine · Pantomin

Resolves to

Compound
UNII7K81IL792LCAS16816-67-4ChEMBLCHEMBL2104786ChEBI31959PubChem452306KEGGD01234
Clinical / RWD
RxNorm32863ATCA11HA32
Structure
InChIKeyDJWYOLJPSHDSAL-ROUUACIJSA-NSMILESCC(C)(CO)[C@@H](O)C(=O)NCCC(=O)NCCSSCCNC(=O)CCNC(=O)[C@H](O)C(C)(C)CO
Targets
O00487PSMD14

What you can answer from here — as of July 06, 2026

1Protein targetEach mapped to UniProt, with action and pharmacological action
Listed above
1Clinical trialPhase, status and sponsor resolved per trial
Sign in
1Structured indicationCondition, population, route and combination as fields, not prose
Sign in
1ContraindicationEach with its own population and attribute set
Sign in
3Marketed productsAcross 2 countries and 3 labellers
Sign in
1ATC codeIncluding every combination product, plus 5 drug categories
Sign in
4+ReferencesStructured and connected to the statements they support
Sign in

Which drugs share a target with Pantethine, and which of those have an active Phase 3 trial?

Answer this in Biopharma OSSign in to your account

Create a free account or log in to explore the full data card.

Create Account
Log InPaid Account Log In